Form 4 for TAK TAKEDA PHARMACEUTICAL CO LTD
Accepted 2026-07-06 18:04:18 ET · period of report 2026-07-01 · accession 0001395064-26-000250 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-06 18:04 | 2026-07-01 | TAK | Ricci Gabriele | Chief Data, Tech. Off | A - Grant | $0.00 | +37.6K | 196.7K | +24% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares | 2026-07-01 | A | A | 37,616 | $0.00 | 196,742 | D | — | — | (F1) Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027. |